Evidence map›Paper›PMID 22738634›Full record

ArticleBioorganic & medicinal chemistry letters2012

Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.

Joshua A Hartsel, Dawn M Wong, James M Mutunga, Ming Ma, Troy D Anderson, Ania Wysinski, Rafique Islam, Eric A Wong, Sally L Paulson, Jianyong Li and 4 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Cysteine-Targeted Insecticides againstACS medicinal chemistry letters · 2020
    Article
  4. Mosquito Acetylcholinesterase as a Target for Novel Phenyl-Substituted Carbamates.International journal of environmental research and public health · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Inhibitor profile ofPesticide biochemistry and physiology · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Joshua A HartselDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Dawn M Wong
James M Mutunga
Ming Ma
Troy D Anderson
Ania Wysinski
Rafique Islam
Eric A Wong
Sally L Paulson
Jianyong Li
Polo C H Lam
Maxim M Totrov
Jeffrey R Bloomquist
Paul R Carlier
Virginia Tech · USMolsoft (United States) · USUniversity of Florida · US

Funding

Development of vector-specific, resistance-breaking insecticides to reduce malariR01AI082581 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI CARLIER, PAUL R · 2009 to 2013
$3.4M
NIAID NIH HHS AI082581NIAID NIH HHS R01 AI082581
6 · The paper itself

Abstract

To identify potential human-safe insecticides against the malaria mosquito we undertook an investigation of the structure-activity relationship of aryl methylcarbamates inhibitors of acetylcholinesterase (AChE). Compounds bearing a β-branched 2-alkoxy or 2-thioalkyl group were found to possess good selectivity for inhibition of Anopheles gambiae AChE over human AChE; up to 530-fold selectivity was achieved with carbamate 11d. A 3D QSAR model is presented that is reasonably consistent with log inhibition selectivity of 34 carbamates. Toxicity of these compounds to live Anopheles gambiae was demonstrated using both tarsal contact (filter paper) and topical application protocols.

Indexed as

AcetylcholinesteraseAnimalsAnophelesCarbamatesCholinesterase InhibitorsHumansModels, MolecularMolecular StructureQuantitative Structure-Activity RelationshipAcetylcholinesteraseCarbamatesCholinesterase Inhibitorsmethyl carbamate

Identifiers

PMID22738634
PMCPMC3389130
OpenAlexW2067776623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.